Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of losartan on intraocular pressure in hypertensive patients
IRCT20210125050134N1Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of losartan in hypertension (HTN), sponsored by Isfahan University of Medical Sciences. Primary endpoint: Reduction in intraocular pressure after losartan therapy. Started Jun 2021; status: completed.
02
Drugs
losartan
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on IRCT20210125050134N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210125050134N1.